Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Chem Biol Interact ; 164(3): 147-56, 2006 Dec 15.
Article in English | MEDLINE | ID: mdl-17069779

ABSTRACT

Compelling evidence indicates that some endocrine disrupters (EDs), acting as selective estrogen-receptor modulators, interfere with osteoblast differentiation and function. Hence, we investigated whether four EDs [bisphenol-A (BSP), benzophenone-3 (BP3), resveratrol and silymarin] affect differentiation and growth of rat calvarial osteoblast-like (ROB) cells in primary in vitro culture. ROB cells were cultured for up 30 days in a medium supplemented with fetal calf serum (FCS), and conventional RT-PCR detected the expression of collagen-1alpha and osteonectin mRNAs through the entire culture period. Real time-PCR demonstrated that at days 2 and 7 of culture the expressions of collagen-1alpha and osteonectin were very low, and underwent a 192- and a 334-fold increase, respectively, at day 21 of culture. In contrast, osteocalcin expression remained unchanged from days 2 to 21 of culture. EIA showed that ROB cells secreted sizeable amounts of osteocalcin and osteopontin between days 13 and 15 of culture. EDs were added at day 13 of culture at concentrations ranging from 10(-10) to 10(-6) M, being the culture medium deprived of FCS, and their effects were tested 48 h later. None of EDs was found to affect osteocalcin and osteopontin secretion from ROB cells, suggesting that their effects were tested at a relatively earlier stage of culture, when ROB cell differentiation into osteoblats is not fully accomplished, and/or the presence of estrogens contained in FCS is needed for EDs to exert their osteoblast-differentiation modulating action. BSP and BP3, but not resveratrol and silymarin, decreased proliferative activity of cultured ROB cells, a cytotoxic effect conceivably independent of their estrogen-receptor modulating activity.


Subject(s)
Benzophenones/pharmacology , Gene Expression Regulation/drug effects , Osteoblasts/drug effects , Phenols/pharmacology , Silymarin/pharmacology , Skull/drug effects , Stilbenes/pharmacology , Animals , Benzhydryl Compounds , Biomarkers , Cell Proliferation/drug effects , Cells, Cultured , DNA, Complementary/genetics , Endocrine System/drug effects , Osteoblasts/cytology , Osteoblasts/metabolism , Rats , Rats, Wistar , Resveratrol , Skull/metabolism
2.
Int J Mol Med ; 17(4): 633-6, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16525720

ABSTRACT

Atrial natriuretic peptide (ANP) is a regulatory hormone widely expressed, along with its receptors, in organs and body tissues. ANP is well known to inhibit aldosterone secretion from mammalian adrenals, but its effect on glucocorticoid-hormone production is controversial. In vivo experiments showed that prolonged ANP administration raised the plasma concentration of cortisol in both normal and dexamethasone/captopril-treated guinea pigs (i.e. in animals with pharmacologically interrupted hypothalamic-pituitary-adrenal axis and renin-angiotensin system). ANP did not affect cortisol secretion from dispersed guinea pig zona fasciculata-reticularis cells, but enhanced catecholamine release from adrenomedullary cells. ANP stimulated cortisol output from guinea pig adrenal slices containing medullary chromaffin tissue, and the beta-adrenoceptor antagonist l-alprenolol blocked this effect. The conclusion is drawn that ANP, when the structural integrity of the adrenal gland is preserved, is able to enhance glucocorticoid secretion in guinea pigs, through an indirect mechanism involving the rise in the catecholamine release, which in turn, acting in a paracrine manner, stimulate secretion of inner adrenocortical cells.


Subject(s)
Adrenal Glands/drug effects , Atrial Natriuretic Factor/pharmacology , Hydrocortisone/metabolism , Adrenal Glands/metabolism , Adrenal Medulla/drug effects , Adrenal Medulla/metabolism , Alprenolol/administration & dosage , Alprenolol/pharmacology , Angiotensin-Converting Enzyme Inhibitors/administration & dosage , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Animals , Atrial Natriuretic Factor/administration & dosage , Captopril/administration & dosage , Captopril/pharmacology , Catecholamines/metabolism , Dexamethasone/administration & dosage , Dexamethasone/pharmacology , Dose-Response Relationship, Drug , Epinephrine/metabolism , Female , Glucocorticoids/administration & dosage , Glucocorticoids/pharmacology , Guinea Pigs , Hydrocortisone/blood , In Vitro Techniques , Injections, Subcutaneous , Male , Norepinephrine/metabolism , Paracrine Communication/drug effects , Paracrine Communication/physiology
3.
Int J Mol Med ; 15(3): 411-5, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15702230

ABSTRACT

Cerebellin (CER) is a regulatory peptide, originally isolated from rat cerebellum, which derives from the cleavage of precerebellin (Cbln), three types of which (Cbln1-3) have been identified in humans and rats. CER is also expressed in several extra-cerebellar tissues, including adrenal gland, and evidence has been provided that CER exerts a modulatory action on human and rat adrenal gland. Hence, we have investigated the expression of Cbln1-3 mRNAs and CER protein-immunoreactivity (IR) in the various zones of rat adrenal glands, and the effects of CER and its metabolite [des-Ser(1)]CER (des-CER) on the secretion and growth of cultured rat adrenocortical cells. Reverse transcription-polymerase chain reaction showed high and low expression of Cbln2 mRNA in zona glomerulosa (ZG) and zona fasciculata-reticularis, respectively. Cbln1 was not expressed, and Cbln3 mRNA was detected only in ZG. No Cbln expression was found in adrenal medulla. Immunocytochemistry demonstrated the presence of CER-IR exclusively in the adrenal cortex, the reaction being more intense in ZG. As expected, ACTH (10(-8) M) markedly enhanced corticosterone secretion and lowered proliferation rate of cultured adrenocortical cells. CER was ineffective, while des-CER exerted an ACTH-like effect, but only at the lowest concentration (10(-10) M). Taken together, these findings allow us to conclude that CER is expressed in rat adrenal cortex, and to suggest that CER conversion to des-CER by endopeptidases is needed for CER to exert its autocrine-paracrine regulatory functions.


Subject(s)
Adrenal Glands/drug effects , Adrenal Glands/metabolism , Gene Expression Regulation , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/pharmacology , Adrenal Glands/cytology , Animals , Cell Proliferation/drug effects , Cells, Cultured , Female , Male , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...